摘要 |
<p>Novel compounds of the formula I in which W, X, Y, T, R<SUP>1 </SUP>and R<SUP>2 </SUP>are as defined in Patent claim 1 , are inhibitors of coagulation factor Xa and can be employed for the prophylaxis and/or therapy of thromboembolic disorders</p> |